We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · February 18, 2021

Tacrolimus 0.1% Is Effective for Facial Vitiligo

Journal of Investigative Dermatology

 

Additional Info

Journal of Investigative Dermatology
Efficacy and Safety of Tacrolimus 0.1% for the Treatment of Facial Vitiligo: A Multicenter Randomized, Double-Blinded, Vehicle-Controlled Study
J Invest Dermatol 2021 Feb 04;[EPub Ahead of Print], J Seneschal, A Duplaine, H Maillard, T Passeron, N Andreu, R Lassalle, C Favary, C Droitcourt, A Taïeb, K Ezzedine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading